We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Lanreotide Autogel in the Treatment of Symptomatic Polycystic Liver Disease (LOCKCYST)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01315795
First Posted: March 15, 2011
Last Update Posted: July 8, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Ipsen
Information provided by (Responsible Party):
Dr Frederik Temmerman, Universitaire Ziekenhuizen Leuven